| Financial Year |
March 31 2023 |
| Monetary Funds |
12,480,796,360.90 |
| Held-for-trading Financial Assets |
1,675,200,753.42 |
| Notes Receivable |
102,267,079.53 |
| Accounts Receivable |
21,787,801,058.06 |
| Advances to Suppliers |
1,273,068,444.06 |
| Other Receivables |
187,894,756.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
9,507,496,954.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,486,558,231.61 |
| Other Current Assets |
929,043,666.02 |
| Total Current Assets |
53,848,010,484.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,011,473,060.09 |
| Long-term Equity Investment |
168,453,376.23 |
| Investment Properties |
81,163,469.40 |
| Fixed Assetes |
9,023,106,982.66 |
| Under-construction Projects |
2,454,702,115.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,338,470,814.50 |
| R&D expenses |
468,080,810.97 |
| Goodwill |
1,444,697.69 |
| Long-Term Deferred and Prepaid Expenses |
52,845,728.71 |
| Deferred Income Tax Assets |
1,282,297,794.77 |
| Other Non-Current Assets |
111,505,198.57 |
| Sub-Total of Non-Current Assets |
20,123,342,661.10 |
| Total Assets |
73,971,353,145.35 |
| Short-Term Loans |
230,241,365.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,374,390,610.54 |
| Accounts Payable |
18,620,059,846.41 |
| Accounts Received In Advance |
99,940,956.56 |
| Employee Compensation Payable |
227,260,410.52 |
| Taxes Payable |
430,618,615.89 |
| Interest Payable |
-- |
| Dividend Payable |
83,380,635.07 |
| Other payables |
976,395,190.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,159,349,262.38 |
| Other Current Liabilities |
431,954,172.29 |
| Sub-Total of Current Liabilities |
27,289,294,445.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
140,305,300.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
22,569,877.44 |
| Deferred Income Tax Liabilities |
126,157,135.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
664,795,006.68 |
| Total Liabilities |
27,954,089,451.94 |
| Paid-In Capital(Or Share Stock) |
6,694,502,993.00 |
| Capital Surplus |
8,988,721,068.31 |
| Surplus Reserve |
1,795,378,648.00 |
| LESS:Treasury Stock |
763,580,748.92 |
| Undistributed Profits |
26,430,253,365.18 |
| Minority Stockholder's Interest |
2,900,712,280.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
43,116,551,412.69 |
| Owner's Equity（Stockholder's Equity） |
46,017,263,693.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
73,971,353,145.35 |
